Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Santoni

Showing results (171-180 of 459) with videos related to

Pageof 46
Sort By:
Pathology, Research and Practice|April 15, 2021
Exploring the association between metastatic sites and androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer patients: A meta-analysis of prospective clinical trialsAlessandro Rizzo, Veronica Mollica, Matteo Rosellini, et al.
Translational Andrology and Urology|April 14, 2021
Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative reviewAlessia Cimadamore, Liang Cheng, Marina Scarpelli, et al.
Translational Andrology and Urology|April 14, 2021
Narrative review: update on immunotherapy and pathological features in patients with bladder cancerGaetano Aurilio, Alessia Cimadamore, Antonio Lopez-Beltran, et al.
Cells|June 26, 2020
New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents?Gaetano Aurilio, Alessia Cimadamore, Matteo Santoni, et al.
Targeted Oncology|October 17, 2018
Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted TherapyFrancesco Massari, Vincenzo Di Nunno, Lidia Gatto, et al.
Biochimica Et Biophysica Acta|December 3, 2014
Neuroendocrine differentiation in prostate cancer: novel morphological insights and future therapeutic perspectivesMatteo Santoni, Alessandro Conti, Luciano Burattini, et al.
Expert Review of Anticancer Therapy|April 28, 2018
Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinomaRodolfo Montironi, Alessia Cimadamore, Silvia Gasparrini, et al.
Clinical & Experimental Metastasis|December 16, 2024
Impact of time-of-day administration of immunotherapy on survival in metastatic renal cell carcinoma: the MOUSEION-09 meta-analysisAlessandro Rizzo, Fernando Sabino Marques Monteiro, Veronica Mollica, et al.
Cancer Immunology, Immunotherapy : CII|January 25, 2023
Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 studyAlessandro Rizzo, Veronica Mollica, Valentina Tateo, et al.
Expert Opinion on Pharmacotherapy|June 1, 2018
Tivozanib for the treatment of renal cell carcinomaMatteo Santoni, Francesco Massari, Francesco Piva, et al.
Pageof 46

Showing results (171-180 of 459) with videos related to

Sort By:
Pageof 46
Pathology, Research and Practice|April 15, 2021
Exploring the association between metastatic sites and androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer patients: A meta-analysis of prospective clinical trialsAlessandro Rizzo, Veronica Mollica, Matteo Rosellini, et al.
Translational Andrology and Urology|April 14, 2021
Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative reviewAlessia Cimadamore, Liang Cheng, Marina Scarpelli, et al.
Translational Andrology and Urology|April 14, 2021
Narrative review: update on immunotherapy and pathological features in patients with bladder cancerGaetano Aurilio, Alessia Cimadamore, Antonio Lopez-Beltran, et al.
Cells|June 26, 2020
New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents?Gaetano Aurilio, Alessia Cimadamore, Matteo Santoni, et al.
Targeted Oncology|October 17, 2018
Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted TherapyFrancesco Massari, Vincenzo Di Nunno, Lidia Gatto, et al.
Biochimica Et Biophysica Acta|December 3, 2014
Neuroendocrine differentiation in prostate cancer: novel morphological insights and future therapeutic perspectivesMatteo Santoni, Alessandro Conti, Luciano Burattini, et al.
Expert Review of Anticancer Therapy|April 28, 2018
Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinomaRodolfo Montironi, Alessia Cimadamore, Silvia Gasparrini, et al.
Clinical & Experimental Metastasis|December 16, 2024
Impact of time-of-day administration of immunotherapy on survival in metastatic renal cell carcinoma: the MOUSEION-09 meta-analysisAlessandro Rizzo, Fernando Sabino Marques Monteiro, Veronica Mollica, et al.
Cancer Immunology, Immunotherapy : CII|January 25, 2023
Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 studyAlessandro Rizzo, Veronica Mollica, Valentina Tateo, et al.
Expert Opinion on Pharmacotherapy|June 1, 2018
Tivozanib for the treatment of renal cell carcinomaMatteo Santoni, Francesco Massari, Francesco Piva, et al.
Pageof 46